DIAGNOSES 32822 Inhibited Sexual Excitement 32830 Munchausen's

Total Page:16

File Type:pdf, Size:1020Kb

DIAGNOSES 32822 Inhibited Sexual Excitement 32830 Munchausen's MEDCIN - DIAGNOSES PSYCHIATRIC DISORDERS, CONT. 32822 Inhibited Sexual Excitement 32830 Munchausen's Syndrome 34868 Psychogenic Impotence 38522 Factitious Disorder With Psychological 35818 Female Sexual Arousal Disorder And Physical Symptoms 35819 Male Erectile Disorder 32831 Factitious Disorder, NOS 32823 Female Orgasmic Disorder 32832 Pathological Gambling 32824 Male Orgasmic Disorder 32833 Kleptomania 32825 Premature Ejaculation 32834 Pyromania 32826 Dyspareunia (Not Due To A 33792 Sadistic Triad Physical Condition) 32835 Intermittent Explosive Disorder 32827 Vaginismus (Not Due To A Physical 35072 Trichotillomania Condition) 32837 Impulse Control Disorder, NOS 32828 Sexual Dysfunction, NOS 32838 Adjustment Disorder With Depressed 38523 Female Hypoactive Sexual Desire Mood Due To Physical Condition 32839 Adjustment Disorder With Anxious 38524 Male Hypoactive Sexual Desire Due Mood To Physical Condition 32840 Adjustment Disorder With Mixed 38525 Male Erectile Disorder Due To Emotional Features Physical Condition 32841 Adjustment Disorder With Disturbance 38526 Female Dyspareunia Due To A Of Conduct Physical Condition 32842 Adjustment Disorder With Disturbance 38527 Male Dyspareunia Due To A Of Emotions, Conduct Physical Condition 32843 Adjustment Disorder With Work (Or 35820 Insomnia Related To Axis IIII Mental Academic) Inhibition Disorder (Nonorganic) 36308 Adjustment Disorder With Physical 35821 Insomnia Related Known Axis III Complaints Factor 32844 Adjustment Disorder With Withdrawal 35822 Primary Insomnia 35003 Adjustment Disorder With Denial Of 35823 Hypersomnia Related To Axis IIII Physical Disorder Mental Disorder (Nonorganic) 32845 Adjustment Disorder, NOS 35824 Hypersomnia Related To Known Axis 35665 Reaction To Chronic Stress III Factor 32846 Psychological Factors Affecting 35011 Primary Hypersomnia Physical Condition 38624 Parasomnia Related To Known Axis III 32638 Requiring Hospitalization Factor 30824 Infectious Disease 38625 Mixed Type Sleep Disorder Due To 39998 See, Also: Affected System Known Axis III Factor 90185 Viral 35825 Circadian Rhythm Sleep Disorder 30926 Adenovirus 36303 Advanced 30831 Arbovirus: 36304 Delayed 30832 Fever, Malaise, Rash, 38542 Jet Lag Type Lymphadenopathy 36305 Disorganized 30833 Dengue Fever 36306 Frequently Changing 30834 West Nile Fever 38622 Atypical Dyssomnia 30835 Fever, Malaise, Headache, Myalgia 35826 Nightmare Disorder 30836 Bat Salivary Gland Virus 32672 Sleep Terror Disorder 30837 Colorado Tick Fever 32671 Sleepwalking Disorder 30839 Mayaro-Semliki Forest Virus 38621 Atypical Parasomnia Disease 38623 REM Sleep Behavior Syndrome 30840 Phlebotomus Fever 33707 Factitious Fever 30841 Rift Valley Fever 32829 Factitious Disorder With Psychological 30842 Bunyamwera Group Symptoms 30838 Bunyavirus 36307 Factitious Disorder With Physical 35090 Hantavirus Symptoms 36174 With Renal Syndrome (HFRS) 509 P. S. Goltra, Medcin © Medicomp Systems, Inc. 1997 MEDCIN - DIAGNOSES INFECTIOUS DISEASE, CONT. 30843 Zika Virus 30981 Generalized 30844 Fever, Malaise, Rash, Arthralgia 30982 Traumatic Herpes 30845 Chikungunya 30970 Herpes Zoster 30846 O'nyong-Nyong Fever 33938 With Ophthalmic Complications 30847 Ross River Virus 33939 With Otitis Extema 30848 Sindbis Virus 30985 Infectious Mononucleosis 30849 Fever, Malaise, Hemorrhagic Signs 31172 LassaFever 30850 Kyasanur Forest Disease 31419 Marburg Virus Disease 30851 Congo-Crimean Hemorrhagic Fever 31181 Measles (Rubeola) 30852 Omsk Hemorrhagic Fever 31420 Milker's Nodules 30853 Yellow Fever 31429 Mokola Virus 36175 Arenavirus Infection 31430 Mucormycosis 36286 Argentine Fever 31431 Rhinocerebral 36287 Bolivian Fever 31432 Gastrointestinal 30932 Brill-Zinsser Disease 31433 Disseminated 31407 Chickenpox 31434 Mumps 30913 Cholera 31435 Orchitis 36176 Vibrio Cholerae 31007 Murine (Endemic Flea-Borne) Typhus 36178 Vibrio Cholerae El Tor Fever 31408 Cowpox 31009 Newcastle Disease 30946 Coxsackie Group A Virus Infections 31446 Orchitis 30947 Diarrhea 31447 Gonococcal 30948 Herpangina 31240 Pharyngoconjunctival Fever 33940 Carditis 31023 Rabies 30949 Hand, Foot & Mouth Disease 31025 Respiratory Syncytial Virus Infection 30951 Tracheobronchitis 90235 Retrovirus Infections 31018 Coxsackie Group B Virus Infections 90236 HTLV-I 31019 Pleurodynia 90237 HTLV-II 31410 Cytomegalovirus Colitis 90238 HTLV-III 31409 Cytomegalovirus Disease 34816 HIV -1 Infection 34815 Cytomegalovirus Retinitis 34925 Stage 0 38325 Ebola Virus Hemorrhagic Fever 34926 Stage 1 30953 Echo Virus 34927 Stage 2 (PGL) 30954 Boston Exanthem 34928 Stage 3 (PGL) 30955 Diarrhea 34929 Stage 4 30956 Pneumonia 34930 Stage 5 (ARC) 30957 Hemolytic / Uremic 31779 Acquired Immunodeficiency Syndrome 30958 Myopericarditis (AIDS - HIV-l Stage 6) 30959 Neurologic 33883 Dementia 30960 Pleurodynia 36264 Encephalopathy 30961 Rash 36265 Oral Leukoplakia 30962 Upper Respiratory 33884 Myelopathy 31089 Encephalomyocarditis Viruses 33885 Polyneuropathy 31086 Erythema Infectiousum 36266 Nephritis 30971 Herpes Simplex 90239 HIV-2 Infection 30972 Type I 90240 Lymphadenopathy-Associated Virus 30973 Type II 31312 Roseola Infantum 30974 Esophagitis 31182 Rubella 30975 Eczema Herpeticum 31069 Smallpox (Variola) 30976 Acute Gingivostomatitis 30966 Summer Grippe 30977 Kerato Conjunctivitis 30914 Suppurative Cervicaladenitis 30979 Chronic Perirectal 31070 Vaccinia 30980 Rhinitis 31075 Verruca 510 MEDCIN - DIAGNOSES INFECTIOUS DISEASE, CONT. 31402 Vesicular Stomatitis 30891 Of The Trunk 31183 Viral Exanthem 37343 First Degree 38175 Viral Syndrome 34860 Second Degree 34607 Viremia 30892 Third Degree 31074 Warts 37346 Third, With Deep Necrosis Of 31076 Common Underlying Tissues 31077 Digital 37347 With Loss Of A Body Part 31078 Flat 30893 Of The Upper Limbs 31079 Filiform 37348 First Degree 31080 Plantar 34861 Second Degree 31138 Condylomata Acuminata 30894 Third Degree 90184 Bacterial 37349 Third, With Deep Necrosis Of 30921 Actinomycosis Underlying Tissues 30922 Cervicofacial 37350 With Loss Of A Body Part 36262 Cutaneous 30895 Of The Wrists Or Hands 30923 Pulmonary 37351 First Degree 36263 Madura Foot 34862 Second Degree 30924 Abdominal 30896 Third Degree 30925 Hematogenous 37352 Third, With Deep Necrosis Of 30927 Anthrax Underlying Tissues 36230 Cutaneous 37353 With Loss Of A Body Part 36231 Pulmonary 30897 Of The Lower Limbs 36232 Gastrointestinal 37354 First Degree 36233 Septic 34863 Second Degree 30872 Bacteremia 30898 Third Degree 35847 Streptococcal 37355 Third, With Deep Necrosis Of 35848 Staphylococcal Underlying Tissues 35850 Salmonella 37356 With Loss Of A Body Part 30935 Bartonellosis (Carrion's Disease) 34807 Of Multiple Sites 30936 OroyaFever 37357 First Degree 30937 Verruga Peruana 37358 Second Degree 31084 Bejel (Treponema Pallidum) 37359 Third Degree 30942 Boutonneuse Fever 37360 Third, With Deep Necrosis Of 30878 Brodie's Abscess - Staph Underlying Tissues 30943 Brucellosis 37361 With Loss Of A Body Part 30944 Acute 34808 Of Internal Organs 30945 Chronic 37362 Mouth 36234 Brucella Melitensis 37363 Gums 36235 Brucella Abortus 37364 Tongue 36236 Brucella Suis 37365 Pharynx 36237 Brucella Canis 37366 Larynx 31218 Bubonic Plague 37367 Trachea 30888 Burns 37368 Lung 34806 Of The Eye 37369 Esophagus 37972 Of The Eyelids 37370 Stomach 37973 Chemical Burn 37371 Small Intestine 30889 Of The Face, Head, Or Neck 37372 Colon 37342 First Degree 37373 Rectum 34859 Second Degree 37374 Vagina 30890 Third Degree 37375 Uterus 37344 Third, With Deep Necrosis Of 37376 Involving Under 10% Of The Body Underlying Tissues Surface 37345 With Loss Of A Body Part 511 MEDCIN - DIAGNOSES INFECTIOUS DISEASE, CONT. 37377 Involving 10-19% Of The Body 36254 Osteomyelitis Surface 36255 Urethritis 37378 Involving 20-29% Of The Body 36256 Endometritis Surface 31344 Meningococcemia (Waterhouse- 37379 Involving 30-39% Of The Body Friderichsen Syndrome) Surface 31219 Molluscum Contagiosum 37380 Involving 40-49% Of The Body 31016 Nocardiosis Surface 31448 Orf 37381 Involving 50-59% Of The Body 31437 Parapharyngeal Space Abscess Surface 36145 Paratrachoma 37382 Involving 60-69% Of The Body 31297 Paratyphoid Fever Surface 36179 Type A 37383 Involving 70-79% Of The Body 36180 TypeB Surface 36181 TypeC 37384 Involving 80-89% Of The Body 31252 Pasteurella Multocida Surface 31314 Perirectal Abscess 37385 Involving 90% Or More Of The Body 31315 Anaerobic Streptococcal Surface 31438 Pertussis 30899 Pseudomonas 31082 Pinta (Treponema Carateum) 30900 Proteus 31027 Plague: Yersinia Pestis 34972 Campylobacter Colitis 36228 Pneumonic 31406 Cat Scratch Disease 31452 Pneumococcemia 30952 Diphtheria 31024 Psittacosis 31149 Disseminated Gonococcemia 36285 With Pneumonia 31459 Farcy 31040 Q Fever 30967 Gangrene 31304 Rat-Bite Fever (Spirillum Minus) 30968 Wet (Infected) 31311 Rhinoscleroma 30969 Dry (Ischemic) 36182 Salmonella Infection 33809 Gas 36183 Salmonella Arthritis 31458 Glanders 36184 Carrier State 30965 Granuloma Inguinale 31348 Salmonellosis 31037 Haverhill Fever 34817 Disseminated 34852 Jarisch-Herxheimer Reaction 31358 Scarlet Fever 31002 Leprosy 31359 Surgical 31003 Borderline 31340 Septic Shock (Endotoxic) 31004 Lepromatous 31341 Clostridial 31005 Tuberculoid 31342 Escherichia Coli 31064 Leptospirosis 31343 Klebsiella Pneumoniae 31066 Fort Bragg Fever 31345 Pseudomonas 31067 Myocarditis 31346 Staphylococcal 31068 Weil's Syndrome 30873 Septicemia 31085 Listeriosis 30874 Streptococcal 36238 Erysipelothrix Infection 30875 Staphylococcal 31006 Melioidosis (Pseudomonas Pseudomallei) 36257 Due To Bacteroides 36171 Meningococcal Infection 35849
Recommended publications
  • Molecular Evidence of Novel Spotted Fever Group Rickettsia
    pathogens Article Molecular Evidence of Novel Spotted Fever Group Rickettsia Species in Amblyomma albolimbatum Ticks from the Shingleback Skink (Tiliqua rugosa) in Southern Western Australia Mythili Tadepalli 1, Gemma Vincent 1, Sze Fui Hii 1, Simon Watharow 2, Stephen Graves 1,3 and John Stenos 1,* 1 Australian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong 3220, Australia; [email protected] (M.T.); [email protected] (G.V.); [email protected] (S.F.H.); [email protected] (S.G.) 2 Reptile Victoria Inc., Melbourne 3035, Australia; [email protected] 3 Department of Microbiology and Infectious Diseases, Nepean Hospital, NSW Health Pathology, Penrith 2747, Australia * Correspondence: [email protected] Abstract: Tick-borne infectious diseases caused by obligate intracellular bacteria of the genus Rick- ettsia are a growing global problem to human and animal health. Surveillance of these pathogens at the wildlife interface is critical to informing public health strategies to limit their impact. In Australia, reptile-associated ticks such as Bothriocroton hydrosauri are the reservoirs for Rickettsia honei, the causative agent of Flinders Island spotted fever. In an effort to gain further insight into the potential for reptile-associated ticks to act as reservoirs for rickettsial infection, Rickettsia-specific PCR screening was performed on 64 Ambylomma albolimbatum ticks taken from shingleback skinks (Tiliqua rugosa) lo- cated in southern Western Australia. PCR screening revealed 92% positivity for rickettsial DNA. PCR Citation: Tadepalli, M.; Vincent, G.; amplification and sequencing of phylogenetically informative rickettsial genes (ompA, ompB, gltA, Hii, S.F.; Watharow, S.; Graves, S.; Stenos, J.
    [Show full text]
  • Histopathology and Laboratory Features of Sexually Transmitted Diseases
    Histopath & Labs for STIs Endo, Energy and Repro 2017-2018 HISTOPATHOLOGY AND LABORATORY FEATURES OF SEXUALLY TRANSMITTED DISEASES Dominck Cavuoti, D.O. Phone: 469-419-3412 Email: [email protected] LEARNING OBJECTIVES: • Identify the etiologic agents causing pelvic inflammatory disease and the pathologic changes they produce. • Discuss the characteristic clinical and pathologic findings caused by herpes simplex virus (HSV) infections: a. fever blisters b. genital herpes simplex virus infection c. disseminated neonatal HSV • Describe the pathologic changes produced by Treponema pallidum. • Describe the clinical features and pathologic changes produced by Chlamydia trachomatisand Neisseria gonorrhoeae • Describe the clinical and laboratory features of vaginal infections including: Trichomonas, Candida, and bacterial vaginosis. • Describe the clinical and laboratory features of ectoparasite infections PURPOSE OF THE LECTURE: 1. To describe the various agents of sexually transmitted diseases and their disease manifestations 2. To describe the pathologic features associated with STDs 3. To introduce some of the laboratory aspects of STDs TERMS INTRODUCED IN LECTURE: Condyloma lata Disseminated gonococcal infection Gummatous syphilis Lymphogranuloma venereum Pelvic inflammatory disease Rapid Plasma Reagin (RPR) Salpingitis Syphilis/endarteritis obliterans Venereal Disease Research Laboratory (VDRL) Treponema pallidum particle agglutination (TPPA) Histopath & Labs for STIs Endo, Energy and Repro 2017-2018 MAJOR CONCEPTS EMPHASIZED IN LECTURE I. Syphilis (Will be covered by Dr. Norgard in later lecture). II. Gonorrhea A. Causative agent: Neisseria gonorrhoeae, a Gram negative diplococcus. Humans are the only natural reservoir. Infection is acquired via direct contact with the mucosa of an infected person. The incubation period averages 2-5 days with a range of 1-14 days.
    [Show full text]
  • Diagnostic Code Descriptions (ICD9)
    INFECTIONS AND PARASITIC DISEASES INTESTINAL AND INFECTIOUS DISEASES (001 – 009.3) 001 CHOLERA 001.0 DUE TO VIBRIO CHOLERAE 001.1 DUE TO VIBRIO CHOLERAE EL TOR 001.9 UNSPECIFIED 002 TYPHOID AND PARATYPHOID FEVERS 002.0 TYPHOID FEVER 002.1 PARATYPHOID FEVER 'A' 002.2 PARATYPHOID FEVER 'B' 002.3 PARATYPHOID FEVER 'C' 002.9 PARATYPHOID FEVER, UNSPECIFIED 003 OTHER SALMONELLA INFECTIONS 003.0 SALMONELLA GASTROENTERITIS 003.1 SALMONELLA SEPTICAEMIA 003.2 LOCALIZED SALMONELLA INFECTIONS 003.8 OTHER 003.9 UNSPECIFIED 004 SHIGELLOSIS 004.0 SHIGELLA DYSENTERIAE 004.1 SHIGELLA FLEXNERI 004.2 SHIGELLA BOYDII 004.3 SHIGELLA SONNEI 004.8 OTHER 004.9 UNSPECIFIED 005 OTHER FOOD POISONING (BACTERIAL) 005.0 STAPHYLOCOCCAL FOOD POISONING 005.1 BOTULISM 005.2 FOOD POISONING DUE TO CLOSTRIDIUM PERFRINGENS (CL.WELCHII) 005.3 FOOD POISONING DUE TO OTHER CLOSTRIDIA 005.4 FOOD POISONING DUE TO VIBRIO PARAHAEMOLYTICUS 005.8 OTHER BACTERIAL FOOD POISONING 005.9 FOOD POISONING, UNSPECIFIED 006 AMOEBIASIS 006.0 ACUTE AMOEBIC DYSENTERY WITHOUT MENTION OF ABSCESS 006.1 CHRONIC INTESTINAL AMOEBIASIS WITHOUT MENTION OF ABSCESS 006.2 AMOEBIC NONDYSENTERIC COLITIS 006.3 AMOEBIC LIVER ABSCESS 006.4 AMOEBIC LUNG ABSCESS 006.5 AMOEBIC BRAIN ABSCESS 006.6 AMOEBIC SKIN ULCERATION 006.8 AMOEBIC INFECTION OF OTHER SITES 006.9 AMOEBIASIS, UNSPECIFIED 007 OTHER PROTOZOAL INTESTINAL DISEASES 007.0 BALANTIDIASIS 007.1 GIARDIASIS 007.2 COCCIDIOSIS 007.3 INTESTINAL TRICHOMONIASIS 007.8 OTHER PROTOZOAL INTESTINAL DISEASES 007.9 UNSPECIFIED 008 INTESTINAL INFECTIONS DUE TO OTHER ORGANISMS
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Rhinoscleroma in an Immigrant from Egypt: a Case Report
    387 BRIEF COMMUNICATION Rhinoscleroma in an Immigrant From Egypt: A Case Report Edgardo Bonacina, MD,∗ Leonardo Chianura, MD, DTM&H,† Maurizio Sberna, MD,‡ Giuseppe Ortisi, MD,§ Giovanna Gelosa, MD,|| Alberto Citterio, MD,‡ Giovanni Gesu, MD,§ and Massimo Puoti, MD† Downloaded from https://academic.oup.com/jtm/article/19/6/387/1795562 by guest on 23 September 2021 Departments of ∗Pathological Anatomy; †Infectious Diseases; ‡Neuroradiology; §Microbiology, and; ||Otorinolaringoiatry, Niguarda Ca` Granda Hospital, Milano, Italy DOI: 10.1111/j.1708-8305.2012.00659.x Rhinoscleroma is a chronic indolent granulomatous infection of the nose and the upper respiratory tract caused by Klebsiella rhinoscleromatis; this condition is endemic to many regions of the world including North Africa. We present a case of rhinoscleroma in a 51-year-old Egyptian immigrant with 1-month history of epistaxis. We would postulate that with increased travel from areas where rhinoscleroma is endemic to other non-endemic areas, diagnosis of this condition will become more common. hough rarely observed, rhinoscleroma has to be nasal fossae and ethmoid sinuses with complete bony T taken into consideration in travelers returning destruction of bilateral nasal turbinates (Figure 1). with ear, nose, and throat presentations, particularly Endoscopic biopsy was performed under local anesthe- after traveling to developing countries or regions where sia. Histopathologic examination revealed numerous this condition is endemic.1,2 foamy macrophages (Mikulicz cells) containing bacteria (Figure 2); no fungal hyphae were found.3 Staphylococcus Case Report aureus and Klebsiella rhinoscleromatis were isolated by culture of the tissue biopsy. A diagnosis of rhinoscle- A 51-year-old Egyptian male immigrant presented on roma was made.
    [Show full text]
  • Genital Dermatology
    GENITAL DERMATOLOGY BARRY D. GOLDMAN, M.D. 150 Broadway, Suite 1110 NEW YORK, NY 10038 E-MAIL [email protected] INTRODUCTION Genital dermatology encompasses a wide variety of lesions and skin rashes that affect the genital area. Some are found only on the genitals while other usually occur elsewhere and may take on an atypical appearance on the genitals. The genitals are covered by thin skin that is usually moist, hence the dry scaliness associated with skin rashes on other parts of the body may not be present. In addition, genital skin may be more sensitive to cleansers and medications than elsewhere, emphasizing the necessity of taking a good history. The physical examination often requires a thorough skin evaluation to determine the presence or lack of similar lesions on the body which may aid diagnosis. Discussion of genital dermatology can be divided according to morphology or location. This article divides disease entities according to etiology. The clinician must determine whether a genital eruption is related to a sexually transmitted disease, a dermatoses limited to the genitals, or part of a widespread eruption. SEXUALLY TRANSMITTED INFECTIONS AFFECTING THE GENITAL SKIN Genital warts (condyloma) have become widespread. The human papillomavirus (HPV) which causes genital warts can be found on the genitals in at least 10-15% of the population. One study of college students found a prevalence of 44% using polymerase chain reactions on cervical lavages at some point during their enrollment. Most of these infection spontaneously resolved. Only a minority of patients with HPV develop genital warts. Most genital warts are associated with low risk HPV types 6 and 11 which rarely cause cervical cancer.
    [Show full text]
  • Unusual Presentation of Rhinoscleroma Dehadaray A1, Patel M2, Kaushik M3, Agrawal D4
    Case Report Unusual presentation of Rhinoscleroma Dehadaray A1, Patel M2, Kaushik M3, Agrawal D4 ABSTRACT Rhinoscleroma or respiratory scleroma is a chronic, slowly progressive, inflammatory disease of the upper respiratory tract. Here we present a 35 year old male presenting with unilateral orbital complaints and non- specific findings on radiological examination, diagnosed only by histopathology as Rhinoscleroma. Due to the low incidence of this disease and its rare presentation in this case, diagnosis was a challenge, but outcome was successful. Keywords- Rhinoscleroma, Orbit 1 MS ENT, Professor, 2 MS DNB ENT, Assistant Professor, 3 MS ENT, Professor and Head, 4 PG student, Department of ENT and HNS, Bharati Vidyapeeth Deemed University Medical College, Pune-411043. Corresponding Author: Dr. Monika Patel, Assistant Professor, Bharati Vidyapeeth Deemed University Medical College, Pune, Maharashtra. Mob: +919028738326 Email: [email protected] 32 The Indian Practitioner q Vol.70 No.11. November 2017 Case Report Introduction hinoscleroma is a chronic progressive, specific granulomatous infectious disease affecting the Rupper respiratory tract associated with Klebsiella rhinoscleromatis infection. It is endemic in Central and South America, Central Africa, Middle East, parts of Europe, India, and Indonesia [1]. It most commonly af- fects the nose [2]. Cases of Rhinoscleroma with invasion into the or- bits are rare, with very few cases reported in litera- ture. Ophthalmologists should also be aware of the Fig 1a Fig 1b disease and the problems in its management. We pres- ent a case of Rhinoscleroma which posed difficulty in with reduced movements in all directions, and vision diagnosing due to its clinical resemblance with other of 6/18.
    [Show full text]
  • Rhinoscleroma
    Eur J Rhinol Allergy 2020; 3(2): 53-4 Image of Interest Rhinoscleroma Seepana Ramesh , Satvinder Singh Bakshi Department of ENT and Head & Neck Surgery, AIIMS Mangalagiri, Guntur, India A 22-year-old man presented with a 6-month history of bilateral nasal obstruction and nasal discharge that was associated with intermittent mild episodes of blood-tinged nasal discharge since 2 months. On examination, a pinkish irregular mass was observed in both the nostrils with complete obstruction of the right nostril. Computed tomography revealed a non-en- hanced homogeneous mass in the left frontal, ethmoid, and maxillary sinuses that extended to both the nasal cavities (Figure 1). Histopathology revealed fragments of granulation tissue with inflammatory cells comprising several foamy to vacuolated histiocytes and plasma cells, suggestive of rhinoscleroma (Figure 2). The patient underwent surgical debridement of the mass and received ciprofloxacin 500 mg twice daily for 6 weeks. He was asymptomatic at 4 months of follow-up. Rhinoscleroma is a chronic granulomatous disease affecting the region between the nose and the subglottis. It is caused by the gram-negative bacillus Klebsiella rhinoscleromatis and spreads by inhalation of contaminated droplets (1). The symptoms depend on the stage of the disease. In the atrophic stage, patients present with fetid nasal dis- charge and crusting, followed by the granulomatous stage, wherein patients develop epistaxis and nasal deformity, secondary to the destruction of the nasal cartilages (1). The final stage is the sclerotic stage, in which patients present with thick dense scars in the nose and upper airway, leading to complete nasal obstruction and even stridor due to laryngeal stenosis (1).
    [Show full text]
  • 8/12/19 1 •Chlamydia •Gonorrhea •Trichomoniasis *Syphilis •Herpes
    8/12/19 Disclosures • Lupin: Advisory committee for Solosec • Merck: Nexplanon trainer • Pfizer pharmaceutical: Advisory Committee for Menopause Questionnaire/teaching tool • TherapeuticsMD: Advisory Committee for vaginal hormone insert Shelagh Larson DNP, APRN, WHNP, NCMP Distinguish the differential diagnosis of STI. Objectives • 1. The attendees will recognize the non-genital presentations of sexually transmitted infection in women and men. •Chlamydia •Herpes • 2. The attendees will understand the prescription therapy for STIs in alternative sites. •Gonorrhea •HPV • 3. The attendees will know the differential diagnosis of STI and other tradition infections. •Trichomoniasis •HIV *Syphilis STI Presentations Discharge Syndrome Genital Ulcer Syndromes Dermatologic Syndromes • Chlamydia • Herpes Simplex HPV Virus • Gonorrhea Secondary Syphilis • Primary Syphilis Disseminated Gonococcal • Trichomoniasis • Chancroid Infection • Bacterial vaginosis Pediculosis Pubis • Candidiasis 1 8/12/19 Facts • most frequently reported bacterial sexually transmitted infection in the US • The silent disease 75% of infected females and 50% males do not realize they have it • Transmitted: vaginally, anal, oral • Once an infected person has completed antibiotic treatment, they should be re-tested after approximately three months to make sure the condition is cured. • Almost 2/3 of new chlamydia infections occur among youth aged 15-24 years. most frequently reported bacterial STI in the United States • known as a ‘silent’ infection because most infected people
    [Show full text]
  • A Novel Murine Model of Rhinoscleroma Identifies Mikulicz Cells, the Disease Signature, As IL-10 Dependent Derivatives of Inflammatory Monocytes
    OPEN TRANSPARENT Research Article ACCESS PROCESS IL-10 controls maturation of Mikulicz cells A novel murine model of rhinoscleroma identifies Mikulicz cells, the disease signature, as IL-10 dependent derivatives of inflammatory monocytes Cindy Fevre1y, Ana S. Almeida2,3y, Solenne Taront2,3, Thierry Pedron2,3, Michel Huerre4, Marie-Christine Prevost5, Aure´lie Kieusseian6,7, Ana Cumano6,7, Sylvain Brisse1, Philippe J. Sansonetti2,3,8,Re´gis Tournebize2,3* Keywords: IL-10; inflammatory Rhinoscleroma is a human specific chronic disease characterized by the monocytes; Klebsiella; Mikulicz cell; formation of granuloma in the airways, caused by the bacterium Klebsiella rhinoscleroma pneumoniae subspecies rhinoscleromatis, a species very closely related to K. pneumoniae subspecies pneumoniae. It is characterized by the appearance of specific foamy macrophages called Mikulicz cells. However, very little is known DOI 10.1002/emmm.201202023 about the pathophysiological processes underlying rhinoscleroma. Herein, we Received September 14, 2012 characterized a murine model recapitulating the formation of Mikulicz cells in Revised January 31, 2013 lungs and identified them as atypical inflammatory monocytes specifically Accepted February 14, 2013 recruited from the bone marrow upon K. rhinoscleromatis infection in a CCR2- independent manner. While K. pneumoniae and K. rhinoscleromatis infections induced a classical inflammatory reaction, K. rhinoscleromatis infection was characterized by a strong production of IL-10 concomitant to the appearance of Mikulicz cells. Strikingly, in the absence of IL-10, very few Mikulicz cells were observed, confirming a crucial role of IL-10 in the establishment of a proper environment leading to the maturation of these atypical monocytes. This is the first characterization of the environment leading to Mikulicz cells maturation and their identification as inflammatory monocytes.
    [Show full text]
  • Volume - I Ii Issue - Xxviii Jul / Aug 2008
    VOLUME - I II ISSUE - XXVIII JUL / AUG 2008 With a worldwide footprint, Rickettsiosis are diseases that are gaining increasing significance as important causes of morbidity and to an extent mortality too. Encompassed within these are two main groups, viz., Rickettsia spotted fever group and the Typhus group (they differ in their surface exposed protein and lipopolysaccharide antigens). A unique thing about these organisms is that, though they are gram-negative bacilli, they 1 Editorial cannot be cultured in the traditional ways that we employ to culture regular bacteria. They Disease need viable eukaryotic host cells and they require a vector too to complete their run up to 2 Diagnosis the human host. Asia can boast of harbouring Epidemic typhus, Scrub typhus, Boutonneuse fever, North Asia Tick typhus, Oriental spotted fever and Q fever. The Interpretation pathological feature in most of these fevers is involvement of the microvasculature 6 (vasculitis/ perivasculitis at various locations). Most often, the clinical presentation initially Trouble is like Pyrexia of Unknown Origin. As they can't be cultured by the routine methods, the 7 Shooting diagnostic approach left is serological assays. A simple to perform investigation is the Weil-Felix reaction that is based on the cross-reactive antigens of OX-19 and OX-2 strains 7 Bouquet of Proteus vulgaris. Diagnosed early, Rickettsiae can be effectively treated by the most basic antibiotics like tetracyclines/ doxycycline and chloramphenicol. Epidemiologically almost omnipresent, the DISEASE DIAGNOSIS segment of this issue comprehensively 8 Tulip News discusses Rickettsiae. Vector and reservoir control, however, is the best approach in any case.
    [Show full text]
  • “Epidemiology of Rickettsial Infections”
    6/19/2019 I have got 45 min…… First 15 min… •A travel medicine physician… •Evolution of epidemiology of rickettsial diseases in brief “Epidemiology of rickettsial •Expanded knowledge of rickettsioses vs travel medicine infections” •Determinants of Current epidemiology of Rickettsialinfections •Role of returning traveller in rickettsial diseaseepidemiology Ranjan Premaratna •Current epidemiology vs travel health physician Faculty of Medicine, University of Kelaniya Next 30 min… SRI LANKA •Clinical cases 12 Human Travel & People travel… Human activity Regionally and internationally Increased risk of contact between Bugs travel humans and bugs Deforestation Regionally and internationally Habitat fragmentation Echo tourism 34 This man.. a returning traveler.. down Change in global epidemiology with fever.. What can this be??? • This is the greatest challenge faced by an infectious disease / travel medicine physician • compared to a physician attending to a well streamlined management plan of a non-communicable disease……... 56 1 6/19/2019 Rickettsial diseases • A travel medicine physician… • Represent some of the oldest and most recently recognizedinfectious • Evolution of epidemiology of rickettsial diseases in brief diseases • Expanded knowledge of rickettsioses vs travel medicine • Determinants of Current epidemiology of Rickettsialinfections • Athens plague described during 5th century BC……? Epidemic typhus • Role of returning traveller in rickettsial diseaseepidemiology • Current epidemiology vs travel health physician • Clinical cases 78 In 1916.......... By 1970s-1980s four endemic rickettsioses; a single agent unique to a given geography !!! • R. prowazekii was identified as the etiological agent of epidemic typhus • Rocky Mountain spotted fever • Mediterranean spotted fever • North Asian tick typhus • Queensland tick typhus Walker DH, Fishbein DB. Epidemiology of rickettsial diseases. Eur J Epidemiol 1991 910 Family Rickettsiaceae Transitional group between SFG and TG Genera Rickettsia • R.
    [Show full text]